CRON
Cronos Group, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.35
−0.59%Forward multiples
Based on analyst estimates
- P/E forward
- 60.91x
- P/E 2026E
- 21.37x
- P/E 2027E
- 29.69x
- P/E 2028E
- 25.54x
- P/S forward
- 5.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.48x
- PEG TTM
- —
- Price / book
- 1.15x
- Price / sales
- 5.08x
- Price / cash flow
- 22.48x
Enterprise value
- Enterprise value
- $487.2M
- EV / sales
- 2.01x
- EV / EBITDA
- 20.00x
- EV / EBIT
- 39.18x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026